Dr. Oğuz Karcıoğlu is a specialist in Chest Diseases at Hacettepe University Faculty of Medicine. After graduating from Hacettepe University in 2011 and completing his specialization in Chest Diseases in 2018, he pursued advanced training in interventional pulmonology at Ruhrlandklinik, University of Essen, and Thoraxklinik, University of Heidelberg in 2023. His research focuses on interstitial lung diseases, cystic fibrosis, and other rare pulmonary conditions. Dr. Karcıoğlu is an active member of the Turkish Thoracic Society and the European Respiratory Society, contributing to both clinical practice and academic advancements in pulmonology.
Profile:
🎓 Educational Background:
Dr. Oğuz Karcıoğlu graduated from the prestigious Hacettepe University Faculty of Medicine in 2011. He completed his residency in Chest Diseases in 2018, building a strong foundation in pulmonary medicine and clinical practice. His dedication to academic growth continued with specialized international training in interventional pulmonology at Ruhrlandklinik, University of Essen, and Thoraxklinik, University of Heidelberg in 2023.
💼 Professional Experience:
Since completing his compulsory service at Çubuk Halil Şıvgın State Hospital after his specialization, Dr. Karcıoğlu has been serving as a faculty member at Hacettepe University Faculty of Medicine, Department of Chest Diseases, since 2021. He is an active member of the Turkish Thoracic Society and the European Respiratory Society, engaging consistently with the academic and professional community. His professional journey reflects a balanced combination of clinical excellence, academic mentorship, and international collaboration.
🏆 Award Contribution:
Through his deep expertise in both common and rare pulmonary conditions, Dr. Karcıoğlu brings a valuable perspective to the Research for Best Researcher Award. His work enhances early diagnosis, procedural innovation, and comprehensive care for patients with challenging respiratory diseases. His dedication to improving clinical outcomes and expanding the scientific understanding of rare lung diseases marks him as a significant contributor to the future of pulmonary medicine.
🔬 Research Focus:
Dr. Karcıoğlu’s research interests are centered around diagnostic and interventional pulmonology, interstitial lung diseases, cystic fibrosis, and other rare lung disorders. His focus on rare diseases underscores his commitment to advancing knowledge in fields that require specialized attention and innovation. By integrating cutting-edge techniques from his international training, he contributes to the refinement of diagnosis and treatment methodologies in respiratory medicine.
Publications:
-
The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients
-
COVID-19: The biggest threat of the 21st century: In respectful memory of the warriors all over the world
-
Ultrasound assessment of sarcopenia in patients with sarcoidosis
-
Pulmonary manifestations of antiphospholipid syndrome: a retrospective analysis of 67 patients
-
What we learned about COVID-19 so far? Notes from underground
-
The contribution of bronchoalveolar lavage in the diagnosis of welder’s lung in a patient with pulmonary fibrosis
-
Comparison of clinical features of cystic fibrosis patients eligible but not on CFTR modulators to ineligible for CFTR modulators
-
Post-discharge mortality in the first wave of COVID-19 in Turkey
-
The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide COVID-19 cohort
-
A basic tool to determine exercise capacity in COPD: 4-meter gait speed
-
Lung cancer from suspicion to treatment: An indicator of healthcare access in Turkey
-
Is there any contribution of bronchial washing to biopsy in the diagnosis of patients with endobronchial pathology in the era of personalized medicine?
-
Diagnostic utility of conventional transbronchial needle aspiration in older patients
-
Effect of modulator therapies on nutritional risk index in adults with cystic fibrosis: A prospective cohort study
-
An 8-year observational study of the death places of patients with COPD in Turkey
-
Who takes care of intensive care? Changes over the last two decades
-
A rare presentation of pulmonary aspergillosis: bronchial stump aspergillosis
-
Investigation of relationship between four meter gait speed test and cardiopulmonary exercise test to determine exercise capacity in COPD patients